Patents Assigned to Ikena Oncology, Inc.
  • TEAD inhibitors and uses thereof
    Patent number: 11925651
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: March 12, 2024
    Assignee: Ikena Oncology, Inc.
    Inventor: Alfredo C. Castro
  • MEK inhibitors and uses thereof
    Patent number: 11878958
    Abstract: The present disclosure provides MEK inhibitors, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: May 25, 2023
    Date of Patent: January 23, 2024
    Assignee: Ikena Oncology, Inc.
    Inventors: Alfredo C. Castro, Michael J. Burke, Thomas A. Wynn, Sabine K. Ruppel, Sergio L. Santillana Soto, Eric Haines, Lan Xu, Oksana Zavidij
  • Tead inhibitors and uses thereof
    Patent number: 11760728
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: September 19, 2023
    Assignee: IKENA ONCOLOGY, INC.
    Inventor: Alfredo C. Castro
  • Aryl hydrocarbon receptor (AHR) agonists and uses thereof
    Patent number: 11608329
    Abstract: The present invention provides AHR agonists, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: March 21, 2023
    Assignee: IKENA ONCOLOGY, INC.
    Inventors: Alfredo C. Castro, Karen J. McGovern, Michael Burke
  • Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[ 1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine maleate as aryl hydrocarbon receptor (AHR) inhibitors
    Patent number: 11591339
    Abstract: The present invention provides solid forms of (R)—N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine maleate (Compound 2) represented by the formula:
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: February 28, 2023
    Assignee: IKENA ONCOLOGY, INC.
    Inventors: Alfredo C. Castro, James Martin Nolan, III, Sarah Jean Bethune, Corinne Marie Folberth
  • AHR inhibitors and uses thereof
    Patent number: 11555026
    Abstract: The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: June 2, 2020
    Date of Patent: January 17, 2023
    Assignee: IKENA ONCOLOGY, INC.
    Inventors: Alfredo C. Castro, Catherine Anne Evans
  • TEAD inhibitors and uses thereof
    Patent number: 11458149
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: October 4, 2022
    Assignee: IKENA ONCOLOGY, INC.
    Inventor: Alfredo C. Castro
  • Indole AHR inhibitors and uses thereof
    Patent number: 11358969
    Abstract: The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: June 14, 2022
    Assignee: IKENA ONCOLOGY, INC.
    Inventors: Alfredo C. Castro, Catherine A. Evans
  • Tead inhibitors and uses thereof
    Patent number: 11274082
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: March 15, 2022
    Assignee: IKENA ONCOLOGY, INC.
    Inventor: Alfredo C. Castro
  • AHR inhibitors and uses thereof
    Patent number: 10696650
    Abstract: The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: June 30, 2020
    Assignee: Ikena Oncology, Inc.
    Inventors: Alfredo C. Castro, Catherine Anne Evans
  • Indole AHR inhibitors and uses thereof
    Patent number: 10689388
    Abstract: The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: June 23, 2020
    Assignee: Ikena Oncology, Inc.
    Inventors: Alfredo C. Castro, Catherine Anne Evans